Barkhordar M, Rashidi A, Vaezi M, Alijani N, Mousavi SA, Tavakoli Shiraji S, Azari Alanjeq M, Azari Alanjeq M, Abbaszadeh M, Kamranzadeh Fumani H, Bahri T. Hybrid Ganciclovir/Valacyclovir Prophylaxis Reduces CMV Reactivation in High-Risk Allogeneic Stem Cell Transplant Recipients. Int J Hematol Oncol Stem Cell Res. 2025;19(4):310-319.